SCHEMBL7282283

SCHEMBL7282283

CC(N)=CC(=O)CS(=O)(=O)N(C)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 2/20 0.50
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RORC P51449 1/20 0.44
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
HDAC4 P56524 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CA2 P00918 1/20 0.38
AOC3 Q16853 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7282278 1.00 MMP3 (0.50) MMP3MEN1KMT2ARORCNPC1
SCHEMBL7478269 0.82 MMP3 (0.57) MMP3MEN1KMT2ARORCNPC1
SCHEMBL7475586 0.79 MMP3 (0.60) MMP3MEN1KMT2ARORCNPC1
SCHEMBL14452195 0.75 MMP3 (0.56) MMP3MEN1KMT2ARORCNPC1
SCHEMBL7289016 0.73 F2 (0.30)
SCHEMBL20954308 0.73 NPC1 (0.54) MEN1KMT2ANPC1RAB9ACA12
SCHEMBL4876765 0.72 KMT2A (0.52) MMP3MEN1KMT2ANPC1RAB9A
SCHEMBL20954396 0.72 CES1 (0.48) MEN1KMT2AALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL9504244 0.72 CES1 (0.48) MEN1KMT2AALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL9504242 0.72 CES1 (0.48) MEN1KMT2AALDH1A1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4742069-A CALCIUM ANTAGONIST, ANTIANGINA, ANTIISCHEMIC, HYPOTENSIVE HOFFMANN-LA ROCHE INC. (US) 1988-05-03 US disclosed
EP-0166422-A1 Dihydropyridine derivatives, processes and intermediates for their preparation and pharmaceutical preparations containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-01-02 EP disclosed